University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Linking Tau PET to Medial Temporal Lobe Subregions With High Resolution MRI

Recruiting

Conditions: Mild Cognitive Impairment

First Posted Date: 2020-01-31

Last Posted Date: 2023-09-01

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 150

Registration Number: NCT04251130

Locations: 🇺🇸
University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, United States

Hepatocellular Carcinoma Surveillance in Cirrhotics

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma
Cirrhosis

Interventions: Behavioral: Usual care
Behavioral: Opt-out + Incentive
Behavioral: Opt-out

First Posted Date: 2020-01-30

Last Posted Date: 2023-02-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 615

Registration Number: NCT04248816

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions

Not Applicable

Active, not recruiting

Conditions: Opioid-use Disorder
Mental Health Conditions

Interventions: Behavioral: Collaborative Care for Opioid Use Disorders and Mental Health Conditions Plus Certified Recovery Specialists
Behavioral: Collaborative Care for Opioid Use Disorders and Mental Health Conditions
Behavioral: Augmented Usual Care

First Posted Date: 2020-01-28

Last Posted Date: 2025-04-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 567

Registration Number: NCT04245423

Locations: 🇺🇸
Penn Center for Primary Care, Philadelphia, Pennsylvania, United States

Physiological Effects of ANGPTL3 Variants in Humans

Not Applicable

Recruiting

Conditions: Hypocholesterolemia

Interventions: Other: Kinetics test, oral fat tolerance test, and an oral glucose tolerance test.

First Posted Date: 2020-01-21

Last Posted Date: 2025-03-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 50

Registration Number: NCT04234724

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Fruits and Vegetables Incentives Study

Not Applicable

Completed

Conditions: Obesity
Fruit and Vegetable Intake
Healthy Diet

Interventions: Behavioral: Real-Time Incentives Group

First Posted Date: 2020-01-21

Last Posted Date: 2023-01-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 244

Registration Number: NCT04235413

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Phase 2

Active, not recruiting

Conditions: Glioblastoma

Interventions: Drug: INCMGA00012
Drug: INCAGN01876
Drug: SRS
Procedure: Brain surgery

First Posted Date: 2020-01-13

Last Posted Date: 2025-02-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 39

Registration Number: NCT04225039

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions

Not Applicable

Active, not recruiting

Conditions: Healthy
Healthy Aging

Interventions: Other: Fatty meal to challenge the physiological chronobiome in healthy young and old

First Posted Date: 2020-01-13

Last Posted Date: 2025-01-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 48

Registration Number: NCT04225442

Locations: 🇺🇸
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States

18F-FluorThanatrace (PET/CT) in Glioblastoma

Early Phase 1

Terminated

Conditions: Glioblastoma

Interventions: Drug: 18F-FluorThanatrace

First Posted Date: 2020-01-09

Last Posted Date: 2024-06-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 3

Registration Number: NCT04221061

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Niraparib/TTFields in GBM

Phase 2

Active, not recruiting

Conditions: Glioblastoma
Recurrent Glioblastoma
GBM

Interventions: Drug: Niraparib
Device: Optune
Procedure: Planned surgical resection

First Posted Date: 2020-01-09

Last Posted Date: 2025-05-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 30

Registration Number: NCT04221503

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

RescueTEE for In-hospital Cardiac Arrest (ReTEECA Trial)

Not Applicable

Withdrawn

Conditions: ACLS
In-hospital Cardiac Arrest
Cardiac Arrest
Image Guided ACLS
Echocardiography, Transesophageal
Cardiopulmonary Arrest With Successful Resuscitation

Interventions: Diagnostic Test: Tranesophageal Echocardiography

First Posted Date: 2020-01-07

Last Posted Date: 2024-02-28

Lead Sponsor: University of Pennsylvania

Registration Number: NCT04220619

Home Terms & Conditions Privacy Policy